ANI Pharmaceuticals (ANIP)

[Just the facts maam]

LD, I too have thought of Organon, and they do need an R&D team as Merk is currently doing the R&D.

Personally, I see Libigel as having higher peek sales potential than Corti. Libigel becomes a block buster just by replacing compounded and off label testosterone currently being prescribed and will grow from there. Corti will take time to reach blockbuster status.

Whoever made the breast cancer discovery is certainly in on any Libige deal. Odds are it was AbbVie, but Merck is still a possibility.

I think if it were a buyout, the deal would have been closed along time ago. That is why I think a joint partnership is in the cards. Which should, in the long run give ANIP shareholders greater value than a buyout.

JMHO.